Home › Trial NCT07300683
Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma
- Trial IDNCT07300683
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity College, London
- Enrollment24
- Start date2025-11-11
- ConditionsT Cell Acute Lymphoblastic Leukemia · T Cell Lymphoblastic Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.